Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma
Open Access
- 31 March 2006
- journal article
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 131 (3), 697-703.e3
- https://doi.org/10.1016/j.jtcvs.2005.08.012
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Neoadjuvant Chemotherapy Followed by Extrapleural Pneumonectomy in Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2004
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2003
- Advances in the Treatment of Malignant Pleural MesotheliomaChest, 1999
- Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: A feasibility and pharmacokinetic studyThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Multimodality Therapy for Malignant Pleural MesotheliomaChest, 1997
- Chemotherapy in malignant pleural mesothelioma. A review.Journal of Clinical Oncology, 1996
- Optimal management of malignant mesothelioma after subtotal pleurectomy: Revisiting the role of intrapleural chemotherapy and postoperative radiationJournal of Surgical Oncology, 1995
- A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.Journal of Clinical Oncology, 1994
- Extrapleural Pneumonectomy in the Setting of a Multimodality Approach to Malignant MesotheliomaChest, 1993
- Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.Journal of Clinical Oncology, 1992